Mediobanca Banca di Credito Finanziario SpA
F:ME90
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mediobanca Banca di Credito Finanziario SpA
F:ME90
|
IT |
|
I
|
Innocan Pharma Corp
XMUN:IP4
|
IL |
|
Coloplast A/S
CSE:COLO B
|
DK |
|
S
|
Schibsted ASA
XMUN:XPG
|
NO |
|
F
|
Franklin Resources Inc
F:FRK
|
US |
|
L
|
Las Vegas Sands Corp
XMUN:LCR
|
US |
|
S
|
Swiss Re AG
LSE:0QL6
|
CH |
|
NioCorp Developments Ltd
TSX:NB
|
US |
|
Kelly Partners Group Holdings Ltd
ASX:KPG
|
AU |
|
T
|
Tokyo Electron Ltd
F:TKY
|
JP |
|
K
|
Kalbe Farma Tbk PT
F:LCLA
|
ID |
|
Telecom Italia SpA
F:TQI
|
IT |
Wall St Price Targets
ME90 Price Targets Summary
Mediobanca Banca di Credito Finanziario SpA
According to Wall Street analysts, the average 1-year price target for
ME90 is 25.19 EUR with a low forecast of 17.34 EUR and a high forecast of 30.11 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ME90's stock price target?
Price Target
25.19
EUR
According to Wall Street analysts, the average 1-year price target for
ME90 is 25.19 EUR with a low forecast of 17.34 EUR and a high forecast of 30.11 EUR.